MIR548AL: A Potential Drug Target and Biomarker (G100616215)

Target Name: MIR548AL

NCBI ID: G100616215

MIR548AL

Other Name(s): hsa-miR-548al | MicroRNA 548al | hsa-mir-548al | microRNA 548al

MIR548AL: A Potential Drug Target and Biomarker

Mir548AL, also known as interleukin-5 (IL-5), is a cytokine that plays a crucial role in the regulation of allergic responses and immune responses. It is a potent chemoattractant that attracts immune cells, including T-cells, and is involved in the development of asthma, Chronic Obstructive Pulmonary Disease (COPD), and other chronic inflammatory diseases.

MIR548AL is a protein that is expressed in various tissues, including the lungs, heart, kidneys, and intestines. It is a member of the Interleukin-5 receptor family, which is a protein that is expressed in various tissues throughout the body, including the lungs, heart, kidneys, and intestines. The IL-5 receptor is involved in the regulation of cellular processes, including cell growth, differentiation, and inflammation.

Studies have shown that MIR548AL is involved in the regulation of allergic responses and immune responses. It is a potent chemoattractant that attracts immune cells, including T-cells, and is involved in the development of asthma, Chronic Obstructive Pulmonary Disease (COPD), and other chronic inflammatory diseases.

MIR548AL has also been shown to play a role in the regulation of pain perception. It is involved in the modulation of pain sensitivity and the regulation of pain modulation.

MIR548AL is a potential drug target because of its involvement in the regulation of cellular processes and its potential role in the development of chronic inflammatory diseases. It is also a biomarker that can be used to diagnose and monitor the progression of these diseases.

MIR548AL is a protein that is expressed in various tissues, including the lungs, heart, kidneys, and intestines. It is a member of the Interleukin-5 receptor family and is involved in the regulation of cellular processes, including cell growth, differentiation, and inflammation.

Studies have shown that MIR548AL is involved in the regulation of allergic responses and immune responses. It is a potent chemoattractant that attracts immune cells, including T-cells, and is involved in the development of asthma, Chronic Obstructive Pulmonary Disease (COPD), and other chronic inflammatory diseases.

In addition to its role in the regulation of allergic responses and immune responses, MIR548AL has also been shown to play a role in the regulation of pain perception. It is involved in the modulation of pain sensitivity and the regulation of pain modulation.

MIR548AL is a potential drug target because of its involvement in the regulation of cellular processes and its potential role in the development of chronic inflammatory diseases. It is also a biomarker that can be used to diagnose and monitor the progression of these diseases.

MIR548AL is a protein that is expressed in various tissues, including the lungs, heart, kidneys, and intestines. It is a member of the Interleukin-5 receptor family and is involved in the regulation of cellular processes, including cell growth, differentiation, and inflammation. Studies have shown that MIR548AL is involved in the regulation of allergic responses and immune responses. It is a potent chemoattractant that attracts immune cells, including T-cells, and is involved in the development of asthma, Chronic Obstructive Pulmonary Disease (COPD), and other chronic inflammatory diseases.

In addition to its role in the regulation of allergic responses and immune responses, MIR548AL has also been shown to play a role in the regulation of pain perception. It is involved in the modulation of pain sensitivity and the regulation of pain modulation.

MIR548AL is a protein that is expressed in various tissues, including the lungs, heart, kidneys, and intestines. It is a member of the Interleukin-5 receptor family and is involved in the regulation of cellular processes, including cell growth, differentiation, and inflammation. Studies have shown that MIR548AL is involved in the regulation of allergic responses and immune responses. It is a potent chemoattractant that attracts immune cells, including T-cells, and is involved in the development of asthma, Chronic Obstructive Pulmonary Disease (COPD), and other chronic inflammatory diseases.

In addition to its role in the regulation of allergic responses and immune responses, MIR548AL has also been shown to play a role in the regulation of pain perception. It is involved in the modulation of pain sensitivity and the regulation of pain modulation.

MIR548AL is a protein that is expressed in various tissues, including the lungs, heart, kidneys, and intestines. It is a member of the Interleukin-5 receptor family and is involved in the regulation of cellular processes, including cell growth, differentiation, and inflammation. Studies have shown that MIR548AL is involved in the regulation of allergic responses and immune responses. It is a potent chemoattractant that attracts immune cells, including T-cells, and is involved in the development of asthma, Chronic Obstructive Pulmonary Disease (COPD), and other chronic inflammatory diseases.

MIR548AL is a potential drug target because of its involvement in the regulation of cellular processes and its potential role in the development of chronic inflammatory diseases. It is also a biomarker that can be used to diagnose and monitor the progression of these diseases.

Protein Name: MicroRNA 548al

The "MIR548AL Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR548AL comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets